A cost-effectiveness analysis of iStent inject combined with phacoemulsification cataract surgery in patients with mild-to-moderate open-angle glaucoma in France

• Kaspar Nieland,

  Roles Conceptualization, Formal analysis, Methodology, Writing – original draft

  Affiliation Pharmerit International, Rotterdam, The Netherlands

  ⨯
• Antoine Labbé,

  Roles Conceptualization, Methodology, Writing – review & editing

  Affiliations Department of Ophthalmology III, Quinze-Vingts National Ophthalmology Hospital, IHU FOReSIGHT, INSERM-DHOS CIC 1423, Paris, France, Department of Ophthalmology, Ambroise Paré Hospital, AP-HP, Paris Saclay University, Boulogne-Billancourt, France

  ⨯
• Cedric Schweitzer,

  Roles Conceptualization, Methodology, Writing – review & editing

  Affiliation CHU Bordeaux, Department of Ophthalmology, Univ. Bordeaux, ISPED, INSERM, U1219 – Bordeaux Population Health Research Centre, Bordeaux, France

  ⨯
• Gaetan Gicquel,

  Roles Conceptualization, Methodology

  Affiliation Glaukos Corporation, Paris, France

  ⨯
• Joris Kleintjens,

  Roles Conceptualization, Formal analysis, Methodology, Writing – review & editing

  Affiliation Pharmerit International, Rotterdam, The Netherlands

  ⨯
• Amrita Ostawal,

  Roles Writing – review & editing

  Affiliation Pharmerit International, Berlin, Germany

  ⨯
• Maarten Treur,

  Roles Writing – review & editing

  Affiliation Pharmerit International, Rotterdam, The Netherlands

  ⨯
• Heather Falvey

  Roles Conceptualization, Methodology

  * E-mail: heatherfalvey@gmail.com

  Affiliation Glaukos Corp, San Clemente, California, United States of America

  https://orcid.org/0000-0003-4498-215X

  ⨯